Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019)

Nu-Med Plus' (NUMD) quarterly Return on Invested Capital came in at 0.04% in Q3 2019, down 34.08% quarter-over-quarter from 0.06% in Q2 2019.

Nu-Med Plus (NUMD) Return on Invested Capital (2016 - 2019) Analysis & Trends

Nu-Med Plus has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.04% for Q3 2019.

  • Return on Invested Capital for Q3 2019 came in at 0.04%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was 0.04% (changed N/A YoY), and the FY2018 annual result was 0.17%, changed N/A from the prior year.
  • Return on Invested Capital came in at 0.04% for Q3 2019 at Nu-Med Plus, down from 0.06% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q1 2019 to a low of 0.37% in Q3 2017.
  • The 4-year median for Return on Invested Capital is 0.0% (2016), against an average of 0.02%.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 0.00%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 0.00%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.00%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.00%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 0.00%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 0.00%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 0.00%
10 Nu-Med Plus - - - -

Historic Data

Download Data
DateValue
Sep 30, 2019 0.04%
Jun 30, 2019 0.06%
Mar 31, 2019 0.18%
Dec 31, 2018 -0.09%
Sep 30, 2017 -0.37%
Jun 30, 2017 -0.01%
Mar 31, 2017 0.00%
Dec 31, 2016 0.00%